Atlas Trials

IMPACT-D+: Immune-Modulating and Psychometric Effects of Accelerated TMS in Depression Plus Comorbid Post-COVID-19 Condition

Clinical trial NCT07197138 · RECRUITING

Trial details

NCT number
NCT07197138
Sponsor
Max-Planck-Institute of Psychiatry
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Depressive DisorderPost-Acute COVID-19 Syndrome
Start date
2025-09-11
Primary completion
2026-05-01
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.